F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug [...]
The agency’s high-level turnover and conflicting policy decisions on drug [...]
Dr. Richard Pazdur, who has been the F.D.A.’s top cancer [...]
The pioneering Danish drugmaker was once the most valuable company [...]
Novo Nordisk slashed its financial forecasts as it struggled to [...]
How the new health secretary, Robert F. Kennedy Jr., is [...]
The regulatory agency confronts a future determined by a health [...]
The Danish drugmaker, which makes Ozempic and Wegovy, has seen [...]
At a hearing, Dr. Marty Makary, the nominee for F.D.A. [...]
Dr. Marty Makary will testify before the Senate health committee [...]
The TV celebrity and Trump nominee has pledged to divest [...]